Skip to main content
. 2022 Jul 19;12:12282. doi: 10.1038/s41598-022-16688-0

Table 1.

Participant characteristics.

N (female:male) 223 (142:81)
Age (years) 66 (53–73)
BMI (kg/m2) 23.1 (21.2–26.4)
Abdominal circumference (cm) 83.9 (77.0–90.8)
Subcutaneous fat area (cm2) 162.7 (108.1–221.8)
Visceral fat area (cm2) 86.1 (53.1–119.0)
HbA1c (%) 5.8 (5.6–6.2)
HOMA–R 1.4 (0.9–2.2)
T-Chol (mg/dL) 194.0 (174.0–215.0)
TG (mg/dL) 108.0 (77.0–154.5)
HDL-Chol (mg/dL) 57.0 (48.5–70.0)
XOR activity (pmol/h/mL) 42.7 (25.3–78.6)
UA (mg/dL) 5.3 (4.5–6.2)
UACR 0.46 (0.40–0.55)
L/S ratio 1.3 (1.2–1.5)
HSI 32.6 (29.3–37.9)
AST (U/L) 20.0 (16.0–25.0)
ALT (U/L) 18.0 (13.0–26.0)
γ-GTP 21.0 (15.8–32.0)
Hypertension 171 (76.7%)
Diabetes 51 (22.9%)
Dyslipidemia 145 (65.0%)

The results are presented as median (interquartile range). BMI, body mass index; HbA1c, hemoglobin A1c; HOMA-R, homeostasis model assessment ratio; T-Chol, total-cholesterol; TG, triglycerides; HDL-Chol, high-density lipoprotein-cholesterol; XOR, xanthine oxidoreductase; UA, uric acid; UACR, urine uric acid to creatinine ratio; L/S, liver-to-spleen; HSI, hepatic steatosis index; AST, aspartate transaminase; ALT, alanine transaminase: γ-GTP, γ-glutamyl transpeptidas.